For PTH-independent hypercalcemia, further evaluation typically involves imaging studies such as chest radiograph, mammogram, or CT scans to rule out malignancy, bone scans to assess for bone metastases or primary bone tumors, and serum and urine protein electrophoresis to evaluate for multiple myeloma. This evidence concerns the gene PTH and hypercalcemia disease.